Evidence map›Paper›PMID 19591575›Full record

ArticleThe Journal of infectious diseases2009

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

Nelson Lee, Paul K S Chan, David S C Hui, Timothy H Rainer, Eric Wong, Kin-Wing Choi, Grace C Y Lui, Bonnie C K Wong, Rita Y K Wong, Wai-Yip Lam and 4 more

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 268 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
268citing papers in PubMed, 12 pooled it
28.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01052961 phase4completednot on this mapstarted 2010, after this paper: background citation

Initiating Oseltamivir in Adults Hospitalized With Influenza -- a Study on the Impact of Virological Clearance and Clinical Recovery for Higher-dose Treatment Started Within 96 Hours

TypeinterventionalSponsorChinese University of Hong KongRan2010 to 2012Enrolled157ConditionsInfluenza, Respiratory Tract InfectionsArmsOseltamivir
NCT01779570 phase4completednot on this mapstarted 2013, after this paper: background citation

Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections

TypeinterventionalSponsorChinese University of Hong KongRan2013 to 2016Enrolled68ConditionsInfluenza, Lower Respiratory Tract InfectionArmsMacrolide treatment
NCT05170009 phase2 / phase3terminatednot on this mapstarted 2022, after this paper: background citation

Randomized Double-blind, Placebo-controlled Single Center Pilot Study to Evaluate the Efficacy and Safety of Baloxavir in Combination With Oseltamivir in Adult Allogeneic Bone Marrow Transplant Recipients With Influenza

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2022 to 2024Enrolled2ConditionsInfluenzaArmsBaloxavir Marboxil, Placebo, Oseltamivir
3 · Its place in the literature

Who cites it

268 citing papers in PubMed, 12 syntheses or guidelines pooled it, 522 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Corticosteroids as adjunctive therapy in the treatment of influenza.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Guideline
  11. Guideline
  12. Pooled it
  13. Trial
  14. Trial
  15. Dexamethasone in Hospitalized Patients with Covid-19.The New England journal of medicine · 2021
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

208 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 5 countries.

Nelson LeeDepartment of Medicine and Therapeutics, Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.
Paul K S Chan
David S C Hui
Timothy H Rainer
Eric Wong
Kin-Wing Choi
Grace C Y Lui
Bonnie C K Wong
Rita Y K Wong
Wai-Yip Lam
Ida M T Chu
Raymond W M Lai
Clive S Cockram
Joseph J Y Sung
Therapeutics Clinical Research · USCzech Academy of Sciences, Institute of Microbiology · CZNational Centre for Infectious Diseases · SGChinese University of Hong Kong · CNNational Critical Care and Trauma Response Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe goal of this study was to characterize viral loads and factors affecting viral clearance in persons with severe influenza.

methodsThis was a 1-year prospective, observational study involving consecutive adults hospitalized with influenza. Nasal and throat swabs were collected at presentation, then daily until 1 week after symptom onset. Real-time reverse-transcriptase polymerase chain reaction to determine viral RNA concentration and virus isolation were performed. Viral RNA concentration was analyzed using multiple linear or logistic regressions or mixed-effect models.

resultsOne hundred forty-seven inpatients with influenza A (H3N2) infection were studied (mean age+/-standard deviation, 72+/-16 years). Viral RNA concentration at presentation positively correlated with symptom scores and was significantly higher than that among time-matched outpatients (control subjects). Patients with major comorbidities had high viral RNA concentration even when presenting>2 days after symptom onset (mean+/-standard deviation, 5.06+/-1.85 vs 3.62+/-2.13 log10 copies/mL; P=.005; beta, +0.86 [95% confidence interval, +0.03 to +1.68]). Viral RNA concentration demonstrated a nonlinear decrease with time; 26% of oseltamivir-treated and 57% of untreated patients had RNA detected at 1 week after symptom onset. Oseltamivir started on or before symptom day 4 was independently associated with an accelerated decrease in viral RNA concentration (mean beta [standard error], -1.19 [0.43] and -0.68 [0.33] log10 copies/mL for patients treated on day 1 and days 2-3, respectively; P<.05) and viral RNA clearance at 1 week (odds ratio, 0.10 [95% confidence interval, 0.03-0.35] and 0.30 [0.10-0.90] for patients treated on day 1-2 and day 3-4, respectively). Conversely, major comorbidities and systemic corticosteroid use for asthma or chronic obstructive pulmonary disease exacerbations were associated with slower viral clearance. Viral RNA clearance was associated with a shorter hospital stay (7.0 vs 13.5 days; P=.001).

conclusionPatients hospitalized with severe influenza have more active and prolonged viral replication. Weakened host defenses slow viral clearance, whereas antivirals started within the first 4 days of illness enhance viral clearance.

Indexed as

Influenza A Virus, H3N2 SubtypeViral LoadVirus SheddingAgedAgingAntiviral AgentsHospitalizationHumansInfluenza, HumanMaleMiddle AgedOseltamivirProspective StudiesTime FactorsAntiviral AgentsOseltamivir

Identifiers

PMID19591575
PMCPMC7110250
OpenAlexW2144674187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.